Crinetics Pharmaceuticals (CRNX) call put ratio 13.7 calls to 1 put into Vertex Pharmaceuticals Incorporated (VRTX) acquiring

Crinetics Pharmaceuticals (NASDAQ: CRNX) 30-day option implied volatility is at 66; compared to its 52-week range of 42 to 92. Call put ratio 13.7 calls to 1 put into Vertex Pharmaceuticals Incorporated (VRTX) acquiring CRNX.

You May Also Be Interested In

• MScience Says Alphabet (GOOGL) Ad Growth Has Moderated in Sept
• Citi reiterates Buy rating on AppLovin with $600 target
• UBS Reiterates Neutral Rating on Yeti Holdings Inc. (YETI) as External Environment Remains Uncertain